Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Pam Devreker

Publications & Research Data

Awards & Distinctions

3 Results

2025

Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer

D. StevensJoline IngelsElisabeth BrabantsSandra Van LintCeline EveraertKarin WeeningKelly HeynsS. DesmetPam DevrekerNele Lootens et al.

2022

Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials

Joline IngelsLaurenz De CockRupert MayerPam DevrekerKarin WeeningKelly HeynsNele LootensSaskia De SmetMarieke BrusseelStijn De Munter et al.

A1 Journal Article in CYTOTHERAPY

2018

An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA loaded dendritic cells for cancer vaccination

Elisabeth BrabantsKelly HeynsS De SmetPam DevrekerJoline IngelsNancy De CabooterVeronique DebackerMelissa DullaersJP Van MeerbeeckBart Vandekerckhove et al.

A1 Journal Article in CYTOTHERAPY